Lis Smedegaard Andersen

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Merete Lund Hetland, B Ejbjerg, Søren Jacobsen et al. · Annals of the Rheumatic Diseases · 2008 · 366 citations

Medicine, Clinical Sciences, Immunology +17

European Multicentre Survey of in Vitro Antimicrobial Resistance in Helicobacter pylori

Y. Glupczynski, Françis Mégraud, M López-Brea et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2001 · 288 citations

Life Sciences, Infectious Diseases, Microbiology +11

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft et al. · Annals of the Rheumatic Diseases · 2017 · 249 citations

Medicine, Clinical Sciences, Internal Medicine +17

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator‐initiated, multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study

Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker et al. · Arthritis & Rheumatism · 2006 · 173 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

Bente Glintborg, Anne Gitte Loft, Emina Omerovic et al. · Annals of the Rheumatic Diseases · 2018 · 155 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14